RecruitingNCT05464849

Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension


Sponsor

National Institute of Cardiology, Laranjeiras, Brazil

Enrollment

150 participants

Start Date

Dec 20, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Systemic arterial hypertension is a serious health problem worldwide. In some cases, it can phenotypically present as resistant arterial hypertension, which consists of blood pressure levels outside the treatment goals in patients using three or more classes of antihypertensive drugs, one of which is preferably a thiazide diuretic. Resistant hypertension contributes to a 47% higher risk of developing cardiovascular events when compared to patients with non-resistant hypertension. It is known that the microcirculation plays a relevant role in the pathophysiology of arterial hypertension. Furthermore, it is known that the cutaneous microvascular network is an adequate model and that it reflects the systemic microcirculation. In this sense, the present research proposes the study of cutaneous capillary density - through high resolution intravital microscopy - and of the endothelium-dependent and independent microvascular vasodilator response - by the speckle laser flowmetry method coupled to a pharmacological system of micro- iontophoresis - in patients diagnosed with resistant hypertension, with the aim of identifying changes in comparison with patients with non-resistant hypertension and normotensive individuals. Additionally, the evaluation of the association between systemic microvascular function and the presence of target organ lesions in this population may indicate that this is a new non-invasive way of stratifying cardiovascular risk in these individuals.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how the tiny blood vessels throughout the body (the microvascular system) function differently in people with resistant hypertension — high blood pressure that doesn't respond to at least 3 medications — compared to those with regular hypertension or healthy controls. Researchers will use a non-invasive test on the skin to measure this. **You may be eligible if...** - You have resistant hypertension (blood pressure that remains high despite 3 or more medications) - OR you have regular (non-resistant) hypertension - OR you are healthy with no known blood pressure issues (for the control group) **You may NOT be eligible if...** - You are pregnant or breastfeeding - For healthy controls: you have any cardiovascular, autoimmune, endocrine, metabolic, or cancer diagnosis - For the hypertension groups: you have certain endocrine diseases or conditions beyond hypertension and diabetes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEvaluation of systemic skin microvascular endothelial function

Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.


Locations(1)

Eduardo Tibiriçá

Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05464849


Related Trials